Sierra Oncology

company

About

Sierra Oncology is a clinical-stage drug development company that advances targeted therapeutics for the treatment of cancer patients.

  • 101 - 250

Details

Last Funding Type
Series D
Last Funding Money Raised
$59.50M
Industries
Biotechnology,Health Care,Life Science,Therapeutics
Founded date
Jan 1, 2004
Number Of Employee
101 - 250
Operating Status
Active

Sierra Oncology is a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer. The company harnesses its deep scientific expertise to identify compounds that target the root cause of disease. Sierra Oncology's team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm. Sierra Oncology is transforming promise into patient impact.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$59.50M
Sierra Oncology has raised a total of $59.50M in funding over 2 rounds. Their latest funding was raised on Apr 21, 2014 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 21, 2014 Series D $59.50M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Sierra Oncology is funded by 1 investors. The Amherst Fund are the most recent investors.
Investor Name Lead Investor Funding Round
The Amherst Fund Series D